tiprankstipranks
Trending News
More News >
Fate Therapeutics (FATE)
NASDAQ:FATE

Fate Therapeutics (FATE) Revenue

Compare
1,263 Followers

Fate Therapeutics Revenue

Fate Therapeutics had a revenue of 1.37M in the quarter ending Dec 31, 2025, with -21.37%. This bring the company's revenue in the last twelve months to 6.65M, Increased -6.88%. In the fiscal year ending Dec 31, 2025, Fate Therapeutics had annual revenue of 6.65M with -51.24% growth.
Revenue (ttm)
6.65M
Revenue Growth
-46.92%
P/S Ratio
25.37
Revenue/Employee
$36,718
Employees
181
Market Cap
$168.58M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
6.65M-6.99M-51.24%
Dec 31, 2024
13.63M-49.90M-78.55%
Dec 31, 2023
63.53M-32.77M-34.03%
Dec 31, 2022
96.30M40.45M+72.44%
Dec 31, 2021
55.85M24.41M+77.66%
Dec 31, 2020
31.43M20.75M+194.33%
Dec 31, 2019
10.68M5.94M+125.32%
Dec 31, 2018
4.74M634.00K+15.44%
Dec 31, 2017
4.11M